Wavefront Announces Audited and Fourth Quarter 2018

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
1,309
Wavefront Announces Audited and Fourth Quarter 2018 Financial Results

EDMONTON, Alberta, Dec. 31, 2018 (GLOBE NEWSWIRE) -- Wavefront Technology Solutions Inc. (Wavefront or the Company, TSX-V: WEE; OTCQX: WFTSF), a global leader in the advancement of dynamic fluid injection technology for oil and gas well stimulation and Improved/Enhanced oil (“IOR/EOR”) recovery announces its audited consolidated financial results for the year and fourth quarter ended August 31, 2018.

The financial highlights for the reporting period are as follows:

  • Wavefront’s total revenue amounted to $3,215,029, an increase of $1,047,489 or 48.3%; compared to $2,167,540 in fiscal 2017 and are principally due to increases in Powerwave stimulation revenues, which increased by $1,526,094 or 119.2% to $2,805,952. Moreover, the Powerwave stimulation increase was due to increased market penetration of Powerwave stimulations particularly in the Middle East which had the largest revenue impact, increasing by $1,671,161 or 369.0% to $2,124,026.  
  • During the fiscal year 2018, the Company began to see the results of its continuing efforts to establish distribution channels beyond selling directly to exploration and production (“E&Ps”) companies by generating $2,664,274 in revenue or 82.9% (2017 - $659,388 in revenue or 30.4%) of revenue through distributor partners beyond the Canadian and USA boarders. The move in sales channels has increased gross profit margins 1 in fiscal 2018 were 82.1% (2017 - 68.6%). By leveraging of Wavefront’s distributor’s reach and focusing on Powerwave stimulation, the Company has also been able to decrease expenses, excluding costs of goods sold and the loss on disposition of property, plant and equipment and inventory of $258,017 (noted below),  by $1,026,324 from the comparative year.           
  • Net losses, as a result, for the year ended August 31, 2018 decreased by $1,919,323 to $1,790,771 (or net loss per share of $0.021), compared to the comparative year’s reported net loss of $3,710,094 (or net loss per share of $0.044).   
  • Fourth quarter 2018 gross revenues (i.e., three months ended August 31, 2018) amounted to $956,626, an increase of $429,189 or 81.4% from the comparative fourth quarter (i.e., three months ended August 31, 2017) revenues of $527,437. Of the revenues for the reporting quarter, $889,655 relates to Powerwave stimulations, with $748,460 of those revenues being derived from the Middle East, an increase of $644,707 or 621.4% over the comparative quarter.
  • Other expenses (i.e., not including costs of goods sold) for the fourth quarter ended August 31, 2018 declined by $112,566 to $1,297,290 compared to $1,409,856 for August 31, 2017.  Inclusive in the fourth quarter 2018 expenses was a non-cash, one-time, write-off of $431,842 against one client’s aged accounts over 120 days, which is consistent with applicable accounting standards. The write-off follows an on-going, aggressive, diligent and verifiable action plan by Wavefront Management and Board of Directors for many months to verify and secure payment from a historically valued and reliable Permian Basin-based client for well stimulation work performed by Wavefront and accepted by the client’s operations manager. It is the intent of the Company’s Management to continue to aggressively pursue and secure the outstanding amount owing including interest, to Wavefront. Should any receipt of payment occur, Wavefront will record a bad debt recovery, i.e., an expense credit, reversing the bad debt expense, and will accordingly disclose.
  • The basic and diluted net income for the fourth quarter, i.e., the three months ended August 31, 2018 was $497,456 (or $0.006 income per share), a decrease of $492,009 from the comparative quarter ended August 31, 2017 which reported a net loss of $989,465 (or $0.012 loss per share). Excluding the non-cash, one-time, bad debt of $431,842 the adjusted net loss 2  for the fourth quarter ended August 31, 2018 decreased by $923,851 or 93.4% to $65,614 (or $0.0008 per share), compared to $989,465 (or $0.012 per share) for the comparative quarter ended August 31, 2017.
  • The adjusted EBITDA loss 2 for the fourth quarter ended August 31, 2018 decreased to $8,257 ($0.0001 per share) compared to the EBITDA loss of $870,769 (or $0.010 per share) for the fourth quarter ended August 31, 2017.  
  • In the fourth quarter 2018, the Company was able to generate cash flows from operations of $194,450, an increase of $605,918 over the comparative quarter. The fourth quarter’s cash flows from operations of $194,450 are also an increase of $131,163 over that generated in the prior quarter (i.e., three months ended May 31, 2018).  
  • Total current assets decreased by $148,733 to $3,624,848 from the prior year end.  Of the net decrease in current assets, $143,079 relates to increased cash resources, which resulted from the closing of a non-brokered private placement of $1,302,400 through the issuance of 4,341,333 units of the Company at a price of $0.30 per unit on July 17, 2018. These increases were offset by cash used in operating activities of $1,176,064.
  • As at August 31, 2018, the Company’s working capital increased to $2,695,737 (August 31, 2017 - $2,686,828). As of December 30, 2018, Wavefront had $2,681,757 of cash and cash equivalents on hand. Of the cash on hand, Wavefront has $1,783,257 in high interest savings accounts with annualized interest rate ranging between 1.85% and 1.95%. There was a net increase in working capital 3 of $824,354 from the prior quarter (i.e., the working capital as at May 31, 2018 of $1,871,383).

The above financial highlights should be read in conjunction with the audited consolidated financial statements, and management discussion and analysis of results for Wavefront for the year and the fourth quarter ended August 31, 2018, which were filed on SEDAR on December 31, 2018.

ON BEHALF OF THE BOARD OF DIRECTORS

WAVEFRONT TECHNOLOGY SOLUTIONS INC.

“D. Brad Paterson” (signed)

D. Brad Paterson, CFO & Director

About Wavefront:

Wavefront is a technology based world leader in fluid injection technology for improved/enhanced oil recovery and well stimulation. Wavefront publicly trades on the TSX Venture Exchange under the symbol WEE and on the OTCQX under the symbol WFTSF. The Company's website is www.onthewavefront.com .

For further information please contact:

D. Brad Paterson, CFO at 780-486-2222 or write to us at investor.info@onthewavefront.com

Cautionary Disclaimer – Forward Looking Statement

Certain statements contained herein regarding Wavefront and its operations constitute “forward-looking statements” within the meaning of Canadian securities laws and the United States Private Securities Litigation Reform Act of 1995. All statements that are not historical facts, including without limitation statements regarding future estimates, plans, objectives, assumptions or expectations or future performance, are “forward-looking statements”. In some cases, forward-looking statements can be identified by terminology such as ‘‘may’’, ‘‘will’’, ‘‘should’’, ‘‘expect’’, ‘‘plan’’, ‘‘anticipate’’, ‘‘believe’’, ‘‘estimate’’, ‘‘predict’’, ‘‘potential’’, “believe”, ‘‘continue’’ or the negative of these terms or other comparable terminology.  We caution that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual results and future events to differ materially from those anticipated in such statements.  Such factors include fluctuations in the acceptance rates of Wavefront’s Powerwave and Primawave Processes, demand for products and services, fluctuations in the market for oil and gas related products and services, the ability of Wavefront to attract and maintain key personnel, technology changes, global political and economic conditions, and other factors that were described in further detail in Wavefront’s continuous disclosure filings, available on SEDAR at www.sedar.com.  Wavefront expressly disclaims any obligation to up-date any “forward-looking statements”, other than as required by law.

©2018 Wavefront Technology Solutions Inc. All rights reserved. From Bit To Last Drop™, WaveAxe™, Powerwave™ and Primawave™ are registered trademarks of Wavefront Technology Solutions Inc., or its subsidiaries, or affiliates.


1 Gross profit margin is calculated by dividing the gross profit by gross revenue. Gross profit is a non-IFRS measure with no comparable IFRS measure 2 Adjusted EBITDA loss is adding back all interest, tax, depreciation and amortization to net loss, and adding back non-cash, one-time, bad debt. EBITDA is an additional IFRS measure with the most comparable IFRS measure being net income (loss), whereas adjusted EBITDA loss is a non-IFRS term with no comparable measure. 3 Working capital is calculated by subtracting current liabilities from current assets. Working capital is a non-IFRS measure with no comparable IFRS measure.

NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 5

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 6

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 5

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 8

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
AI-Driven Lumi Transforms Car Dealership Interactions

Updated Category News Views 7

Lumi: Changing the Car Buying Game Picture this: You're browsing for a new car, head filled with specifics like towing capacity, price points, and trim options. Usually, such queries would send you bouncing around the web, but Lectrium's Lumi promises to keep the questioning—and decision-making—right on the dealership's page. In a move set to shake up the game,...

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 6

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Succession Planning in Turmoil: Only 42% Ready

Updated Category News Views 5

Diving into the Succession Crisis in Finance Succession planning in the financial advisory space is like retirement planning for the rest of us—everyone knows it's crucial, yet too many put it off. Despite the looming retirement wave and desperate interest from the younger cohort, a staggering 42% of financial advisors are still without a documented succession game...

Continue Reading

Top 5 Most Recently Viewed Articles

In-Silico Clinical Trials Expected to Surge to $6.39 Billion

Updated Category News Views 196

In-Silico Clinical Trials Market Overview The in-silico clinical trials market is witnessing substantial growth, projected to reach USD 6.39 billion in the near future. This transformation reflects a significant shift in how pharmaceutical and medical technology companies approach drug development and clinical evaluation. By leveraging advanced digital technologies,...

Continue Reading
Longeveron Inc. Announces Significant Leadership Changes

Updated Category News Views 162

Longeveron Inc. Leadership Evolution Longeveron Inc. has recently made pivotal updates to its leadership team, signaling significant strategic shifts within the company. Than Powell is stepping up as the Interim CEO, while Dr. Joshua Hare, a cornerstone of the company, takes on the role of Executive Chairman of the Board. These changes come as the company aims to enhance...

Continue Reading
Aebi Schmidt Group's Growth Strategy Post-Merger Unveiled

Updated Category News Views 218

Aebi Schmidt Group's Strategic Vision After Merger Aebi Schmidt Group is actively trading under the ticker symbol "AEBI" after completing an exciting merger with The Shyft Group. The organization is well-positioned with a robust balance sheet, focusing on executing its post-merger strategies effectively. Amidst a dynamic operating environment, the company's commitment to...

Continue Reading
Unibail-Rodamco-Westfield Achieves Top ‘A’ Rating in Sustainability

Updated Category News Views 373

Unibail-Rodamco-Westfield's Commitment to Sustainability Unibail-Rodamco-Westfield, often abbreviated as URW, has accomplished an impressive feat by receiving a top ‘A’ rating from CDP for the seventh consecutive year. This recognition is a testament to the company's continuous efforts and transparent actions in combating climate change, all structured under its...

Continue Reading
Genstar Capital Hires Industry Veteran John Kufner for Advisory

Updated Category News Views 280

Big Moves in Private Equity: Genstar's New Addition What’s the deal here? Genstar Capital, that powerhouse in private equity, just scored big by bringing John Kufner on board as part of their Strategic Advisory Board. This isn’t just another hire; it's a strategic chess move. Kufner isn’t your run-of-the-mill executive—he's been around the block more than a few...

Continue Reading